Las Vegas, NV -- (SBWIRE) -- 01/31/2013 -- Beststocksdaily is one of leading U.S. stock update providers to valued investors. Following are the notable volume leaders as reported by http://beststocksdaily.com/
Anacor Pharmaceuticals Inc (NASDAQ:ANAC) fell 17.79% and is trading at $4.25. Anacor Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing small-molecule therapeutics derived from its boron chemistry platform. The Company has discovered, synthesized and developed seven molecules that are in development. Its lead product candidates include two topically administered dermatologic compounds tavaborole and AN2728.
Can ANAC Continues To Move Higher Back? Find Out Here http://beststocksdaily.com/p2/index.php?company=ANAC
Amgen, Inc. (NASDAQ:AMGN) is higher 0.92% and is trading at $86.38. Amgen Inc. (Amgen) is a biotechnology medicines company. The Company discovers, develops, manufactures and markets medicines for illnesses. It focuses solely on human therapeutics and concentrates on medicines based on cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, inflammation and nephrology.
Get Free Trend Analysis on AMGN Here http://beststocksdaily.com/p2/index.php?company=AMGN
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) added 17.09% and is trading at $3.22. Aeterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrine therapy. The Company’s pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products.
To Get complete technical analysis on AEZS go to http://beststocksdaily.com/p2/index.php?company=AEZS
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) fell 1.40% and is trading at $8.44. Arena Pharmaceuticals, Inc. (Arena) is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors (GPCRs), in four therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. After completing various studies, analyses and other activities in response to the lorcaserin CRL, in December 2011, the Company resubmitted the lorcaserin NDA.
Get Free Trend Analysis on ARNA Here http://beststocksdaily.com/p2/index.php?company=ARNA
Gilead Sciences, Inc. (NASDAQ:GILD) is higher 0.79% and is trading at $39.75. Gilead Sciences, Inc. (Gilead) is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Gilead’s primary areas of focus include human immunodeficiency virus (HIV)/AIDS, liver diseases, such as hepatitis B and C and cardiovascular/metabolic and respiratory conditions. The Company has operations in North America, Europe and Asia Pacific.
To Get complete technical analysis on GILD go to http://beststocksdaily.com/p2/index.php?company=GILD
Beststocksdaily’s team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily’s instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.
The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)